InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Garofalo Elizabeth A., 董事. Director active across 3 companies, notably Acadia Pharmaceuticals INC. Aggregated, 15 filings have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €120k. Activity tracked since 16 June 2022. The latest transaction was filed on 2 September 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Garofalo Elizabeth A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
28,700 股Common StockSEC:0001193125-26-274132:0
8,107 股Common StockSEC:0001826361-26-000002:0
1,600 股@ US$25.975329.7% 占其流量Common StockSEC:0001415889-25-023592:0
28,700 股0Common StockSEC:0000950170-25-085618:0
9,387 股Common StockSEC:0001415889-25-015272:0
4,919 股@ US$18.23100.0% 占其流量Common StockSEC:0001415889-25-007299:0
35,000 股0Common StockSEC:0000950170-24-072516:0
6,652 股Common StockSEC:0001415889-24-015088:0
3,500 股@ US$18.56100.0% 占其流量Common SharesSEC:0000950170-24-029542:0
9,459 股0Common StockSEC:0000950170-23-068620:0
2,918 股0Common StockSEC:0001209191-23-056827:0
26,250 股0Common StockSEC:0000950170-23-028267:0
6,391 股Common StockSEC:0001209191-23-034694:0
9,459 股0Common StockSEC:0001209191-22-038536:0
1,918 股Common StockSEC:0001209191-21-058556:0
15 条申报中的 15 条
About Garofalo Elizabeth A.
GAROFALO ELIZABETH A. is Administrateur and has 15 filings in total. Across the 15 filings observed between 2021-10-01 and 2026-06-17, sales total 120100 EUR and the most common transaction nature is Levée d'options. The filings concern Acadia Pharmaceuticals INC, Alector, Inc. and Xenon Pharmaceuticals Inc., including sales at Acadia Pharmaceuticals INC on 2025-03-06 and 2025-09-03.
